Complex regional pain syndrome type I: efficacy of stellate ganglion blockade

J Orthop Traumatol. 2009 Dec;10(4):179-83. doi: 10.1007/s10195-009-0071-5. Epub 2009 Nov 4.

Abstract

Background: This study was performed to evaluate the treatment of complex regional pain syndrome (CRPS) type I with stellate ganglion blockade.

Materials and methods: We performed three blockades at weekly intervals in 22 patients with CRPS type I in one hand. The patients were divided into two groups depending on the time between symptom onset and treatment initiation. Group 1and 2 patients had short and long symptom-onset-to-treatment intervals, respectively. Pain intensity, using a visual analog score (VAS), and range of motion (ROM) for the wrist joint were assessed before and 2 weeks after treatment and were compared using nonparametric statistical analysis.

Results: Treatment produced a statistically significant difference in wrist ROM for all patients (P < 0.001). VAS values showed an overall decrease from 8 +/- 1 to 1 +/- 1 following treatment, and there was a significant difference in VAS value between groups 1 and 2 (P < 0.05).

Conclusions: We concluded that stellate ganglion blockade successfully decreased VAS and increased ROM of wrist joints in patients with CRPS type I. Further, the duration between symptom onset and therapy initiation was a major factor affecting blockade success.

Publication types

  • Clinical Trial

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Anesthetics, Local / administration & dosage
  • Bupivacaine / administration & dosage*
  • Drug Therapy, Combination
  • Female
  • Humans
  • Male
  • Middle Aged
  • Nerve Block / methods*
  • Pain Measurement
  • Prilocaine / administration & dosage*
  • Prospective Studies
  • Range of Motion, Articular
  • Reflex Sympathetic Dystrophy / drug therapy*
  • Stellate Ganglion / drug effects*
  • Treatment Outcome
  • Wrist Joint* / innervation

Substances

  • Anesthetics, Local
  • Prilocaine
  • Bupivacaine